Form 4 for BMY Bristol Myers Squibb
Accepted 2023-11-30 00:00:00 ET · period of report 2023-11-28 · accession 0000014272-23-000189 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-30 | 2023-11-28 | BMY | BOERNER CHRISTOPHER S. | CEO | P - Purchase | $48.86 | +3,071 | 79.4K | +4% | +$150.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.10 par value | 2023-11-28 | P | A | 3,071 | $48.86 | 79,384 | D | — | — |